Hide table of contents

Halstead asks about the performance of groups that EAs have previously funded.

But what about groups that we haven't previously funded, including those that EAs are allied with, or have offered non-monetary support? Who stood out, that we should aim to support in the future?

39

0
0

Reactions

0
0
New Answer
New Comment


9 Answers sorted by

It seems like CEPI has taken pretty good actions (funding RNA vaccine R&D in 2018, funding Moderna in January 2020, leading COVAX). I'm excited about the plan they outline at https://endpandemics.cepi.net/:

  1. Compress vaccine development timelines to 100 days
  2. Develop a universal vaccine against coronaviruses
  3. Develop a library of vaccine candidates against other threats

and hope the EA community will be interested in supporting it. CEPI was initially funded by the Wellcome Trust, Gates Foundation, and several national governments (Norway, Japan, Germany, India), and (according to Wikipedia) have since been supported by the EU Horizon 2020 program and the governments of Australia, Belgium, Canada and the UK.

One example might be Dominic Cummings, who is clearly very influenced by EA ideas, even if he has been somewhat (in my opinion unfairly) shunned by the EA community. It seems he was one of the major forces pushing the UK government towards more decisive action on things like lockdowns. See e.g. here or here.

He was also apparently instrumental in pushing through a big grant for Our World In Data despite the sclerotic procurement process.

even if he has been somewhat (in my opinion unfairly) shunned by the EA community

What's this referring to? I know he consumes a bunch of rationalist content, but wasn't aware of much interaction with EA, or of any action of the community towards him.

Patrick McKenzie isn’t a “group”, and he probably doesn’t need your money, but he did get ahead of coronavirus impacts in Japan successfully: https://www.kalzumeus.com/2020/04/21/japan-coronavirus/

And VaccinateCA was very impressive.

[edit; just found their donation page and they recieved considerable OpenPhil support, so not a candidate based on the OP's criteria].

One Day Sooner seem like a candidate. I don't know if they've received EA support, although at least one EA (David Manheim) works with them. I think they've done good work in bringing attention and legitimacy to the idea of human challenge trials in a pandemic situation, which seems plausibly like a very important thing for future pandemics.
https://www.1daysooner.org/

Several other people who work with them are connected to EA.

The obvious one to me is the adjacent LessWrong-style rationality community, which as a whole took this pandemic at least as seriously as we did fairly early on, and wrote useful and prescient articles like this one on the credibility of the US CDC. 

To me the shining example of this is Jacob Falkovich's Seeing the Smoke, which somehow helped convince the UK to lockdown in March 2020.

A group of us developed coviddash.org which was referenced in the NYTimes and had about ~30K visitors, directing between 10K-20K to vaccine trial screening websites or to the sites themselves. We had sites thank us for patients so we know we our counterfactual impact on trial enrollment was >0, but we are not sure of the total number we actually directed. If we accelerated just one vaccine for just one day though we probably helped save a few hundred lives. We were not funded by any EA org but some of us are EA-aligned.

I plan to write a more detailed recap/analysis on this and to discuss accelerating vaccine R&D during pandemics but haven't gotten to it yet because I already moved onto the next project...

I would add the New England Complex Systems Institute, particularly Yaneer Bar Yam: https://necsi.edu/corona-virus-pandemic 

In this article from January 2020, which has aged very well, they were advocating for restrictions on international movement and warning of the effect of superspreader events on estimates of R0. 

Yaneer Bar Yam also started this multidisciplinary effort to tackle covid: https://www.endcoronavirus.org/ 

Could you give examples of "allies of the EA community, groups that EAs have offered non-monetary support? And what about groups that we haven't previously funded - who stood out, such that we should aim to support them in the future?"

Edit: I think I get what you mean now based on the answers others gave above!

EAs have voted in various elections in the United States. This study adjusted for various factors and found that Republican Party power at the state level was associated with modestly higher amounts of death from COVID-19. Since the majority of EA voters have picked the Democratic Party, this can be taken as something of a vindication. Of course, there are many other issues for deciding your vote besides pandemics, and that study might be wrong. It's not even peer reviewed.

The difference might be entirely explained by politically motivated differences in social distancing behavior between Democratic and Republican citizens, although if that's the case it could still somewhat vindicate opposition to the Republican Party.

Also, the study was done before the vaccine rollout; it will be interesting to see a similar analysis from a later date.

1 Related Questions

Parent Question
Comments1
Sorted by Click to highlight new comments since:

This NYTimes Magazine article might be interesting. Its framing is basically "why did the CDC fail, and how can it do better next time?". 

It mentions some other groups that allegedly did better than the CDC. Though I don't know to what extent these groups were or were not EA-funded. E.g., it says:

The Covid Rapid Response Working Group, at the Edmond J. Safra Center for Ethics at Harvard, was one of several independent organizations that stepped in to help fill the gap. In the last year, these groups, run mostly out of academic centers and private foundations, have transformed reams of raw data — on transmission rates and hospitalization rates and death tolls — into actionable intelligence. They have created county-by-county risk-assessment tools, devised national testing strategies and mapped out national contact-tracing programs. In many if not most cases, they have moved faster than the C.D.C., painting a more accurate picture of the pandemic as it unfolded and offering more feasible solutions to the challenges that state and community leaders were facing.

Curated and popular this week
trammell
 ·  · 25m read
 · 
Introduction When a system is made safer, its users may be willing to offset at least some of the safety improvement by using it more dangerously. A seminal example is that, according to Peltzman (1975), drivers largely compensated for improvements in car safety at the time by driving more dangerously. The phenomenon in general is therefore sometimes known as the “Peltzman Effect”, though it is more often known as “risk compensation”.[1] One domain in which risk compensation has been studied relatively carefully is NASCAR (Sobel and Nesbit, 2007; Pope and Tollison, 2010), where, apparently, the evidence for a large compensation effect is especially strong.[2] In principle, more dangerous usage can partially, fully, or more than fully offset the extent to which the system has been made safer holding usage fixed. Making a system safer thus has an ambiguous effect on the probability of an accident, after its users change their behavior. There’s no reason why risk compensation shouldn’t apply in the existential risk domain, and we arguably have examples in which it has. For example, reinforcement learning from human feedback (RLHF) makes AI more reliable, all else equal; so it may be making some AI labs comfortable releasing more capable, and so maybe more dangerous, models than they would release otherwise.[3] Yet risk compensation per se appears to have gotten relatively little formal, public attention in the existential risk community so far. There has been informal discussion of the issue: e.g. risk compensation in the AI risk domain is discussed by Guest et al. (2023), who call it “the dangerous valley problem”. There is also a cluster of papers and works in progress by Robert Trager, Allan Dafoe, Nick Emery-Xu, Mckay Jensen, and others, including these two and some not yet public but largely summarized here, exploring the issue formally in models with multiple competing firms. In a sense what they do goes well beyond this post, but as far as I’m aware none of t
 ·  · 1m read
 · 
 ·  · 19m read
 · 
I am no prophet, and here’s no great matter. — T.S. Eliot, “The Love Song of J. Alfred Prufrock”   This post is a personal account of a California legislative campaign I worked on March-June 2024, in my capacity as the indoor air quality program lead at 1Day Sooner. It’s very long—I included as many details as possible to illustrate a playbook of everything we tried, what the surprises and challenges were, and how someone might spend their time during a policy advocacy project.   History of SB 1308 Advocacy Effort SB 1308 was introduced in the California Senate by Senator Lena Gonzalez, the Senate (Floor) Majority Leader, and was sponsored by Regional Asthma Management and Prevention (RAMP). The bill was based on a report written by researchers at UC Davis and commissioned by the California Air Resources Board (CARB). The bill sought to ban the sale of ozone-emitting air cleaners in California, which would have included far-UV, an extremely promising tool for fighting pathogen transmission and reducing pandemic risk. Because California is such a large market and so influential for policy, and the far-UV industry is struggling, we were seriously concerned that the bill would crush the industry. A partner organization first notified us on March 21 about SB 1308 entering its comment period before it would be heard in the Senate Committee on Natural Resources, but said that their organization would not be able to be publicly involved. Very shortly after that, a researcher from Ushio America, a leading far-UV manufacturer, sent out a mass email to professors whose support he anticipated, requesting comments from them. I checked with my boss, Josh Morrison,[1] as to whether it was acceptable for 1Day Sooner to get involved if the partner organization was reluctant, and Josh gave me the go-ahead to submit a public comment to the committee. Aware that the letters alone might not do much, Josh reached out to a friend of his to ask about lobbyists with expertise in Cal